Your browser doesn't support javascript.
loading
Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy.
Zeng, Bijun; Middelberg, Anton Pj; Gemiarto, Adrian; MacDonald, Kelli; Baxter, Alan G; Talekar, Meghna; Moi, Davide; Tullett, Kirsteen M; Caminschi, Irina; Lahoud, Mireille H; Mazzieri, Roberta; Dolcetti, Riccardo; Thomas, Ranjeny.
Afiliação
  • Zeng B; Diamantina Institute, Translational Research Institute, and.
  • Middelberg AP; Australia Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia.
  • Gemiarto A; James Cook University, Townsville, Queensland, Australia.
  • MacDonald K; QIMR Berghofer, Brisbane, Queensland, Australia.
  • Baxter AG; James Cook University, Townsville, Queensland, Australia.
  • Talekar M; Diamantina Institute, Translational Research Institute, and.
  • Moi D; Diamantina Institute, Translational Research Institute, and.
  • Tullett KM; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
  • Caminschi I; Burnet Institute, Melbourne, Victoria, Australia.
  • Lahoud MH; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
  • Mazzieri R; Burnet Institute, Melbourne, Victoria, Australia.
  • Dolcetti R; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Thomas R; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
J Clin Invest ; 128(5): 1971-1984, 2018 05 01.
Article em En | MEDLINE | ID: mdl-29485973

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Melanoma Experimental / Receptores Imunológicos / Adjuvantes Imunológicos / Lectinas Tipo C / Apresentação Cruzada / Imunoterapia / Antígenos de Neoplasias Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Melanoma Experimental / Receptores Imunológicos / Adjuvantes Imunológicos / Lectinas Tipo C / Apresentação Cruzada / Imunoterapia / Antígenos de Neoplasias Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2018 Tipo de documento: Article